Premium
Approach to haemangiomatosis causing congestive heart failure
Author(s) -
Tal Roie,
Dotan Moshe,
Lorber Avraham
Publication year - 2016
Publication title -
acta paediatrica
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.772
H-Index - 115
eISSN - 1651-2227
pISSN - 0803-5253
DOI - 10.1111/apa.13359
Subject(s) - medicine , heart failure , percutaneous , propranolol , intensive care medicine , medical therapy , therapeutic modalities , therapeutic approach , surgery , cardiology , disease
Haemangiomas represent the most common tumour of infancy. Although most cases are cutaneous benign lesions, multiple skin haemangiomas are associated with visceral involvement, especially of the liver. Hepatic haemangiomatosis may be complicated by high‐output cardiac failure due to high‐flow arteriovenous connections within the lesions. Different therapeutic strategies for treating haemangiomatosis causing heart failure include medical, surgical and interventional modalities. This study aimed to review the treatment options, discuss their benefits and flaws and propose a practical therapeutic approach for this medical situation. Conclusion Our approach incorporates heart failure medications, dietary support and propranolol as first‐line treatment, while corticosteroids, vincristine, percutaneous intervention and surgery are reserved for refractory cases.